ArticleCurrent oncology (Toronto, Ont.)2022

A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency.

Andrea Visentin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.